Pu Bai,* Peitao Xie* 

Inner Mongolia Medical University Ordos School of Clinical Medicine, Ordos, 017000, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Pu Bai; Peitao Xie, Ordos Center Hospital, No. 6 Sudu Street, Kangbashi District, Ordos City, 017000, People’s Republic of China, Email baipu415@126.com; xiepeitao57@163.com

Objective: To explore the clinical characteristics and treatment outcomes of intracerebral hemorrhage in eosinophilic granulomatosis with polyangiitis (EGPA).
Methods and Patient Presentation: We report an 18-year-old student of EGPA complicated with intracerebral hemorrhage. The laboratory tests showed a continuous increase in eosinophils. The CT of head and chest showed cerebral hemorrhage and pulmonary infiltration.
Interventions: The patient received an intravenous infusion of methylprednisolone 1g/(kg·d) and cyclophosphamide for 3 days, followed by oral prednisone 1 mg/(kg·d).
Outcomes: At discharge, the patient’s head and chest CT showed obvious absorption of intracranial hematoma and improvement of pulmonary infiltration. We reviewed 40 previously published cases of EGPA with intracerebral hemorrhage focusing on the clinical features and treatment of intracerebral hemorrhage caused by EGPA.
Conclusion: For the cases of EGPA complicated with intracerebral hemorrhage, we should timely differentiate diagnosis and recognition. Early diagnosis with aggressive immunosuppressive therapy can help improve the prognosis of patients EGPA with intracerebral hemorrhage. When a patient is affected by EGPA, it is essential to remain vigilant for signs of Central Nervous System involvement. The treatment with glucocorticoids and cyclophosphamide is effective in managing EGPA.

Keywords: Churg Strauss-Syndrome, eosinophilic granulomatosis with polyangiitis, eosinophilia, intracerebral hemorrhage